In a Phase IIb randomized, placebo-controlled trial involving about 160 patients, those who received monthly injections of ION224 for nearly a year showed marked improvements in liver fat, inflammation, and fibrosis, and remarkably, these benefits occurred even without weight loss
First-in-elephant, proof-of-concept vaccination study Study design Study elephants Equivalent to phase I vaccine trial standards, healthy adult elephants rather than EEHV-susceptible calves were chosen for this first-in-elephant proof-of-concept study
Catagen is the transitional phase, lasting approximately two to three weeks
F., & Fraumeni, J
2018 History The KLOW Blend draws on several decades of peptide research, bringing together compounds that have been investigated in diverse experimental contexts
Campbell BJ, Rowbotham M, Davies PS, et al